QMS Medical promoters disclose shareholding under SEBI regulations

qms medical allied services disclosed the shareholding details of its promoters and promoter group members for the period ending March 31, 2026. The disclosure was submitted to the National Stock Exchange of India Ltd. in compliance with Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. The filing confirms that the shares held by these individuals are not encumbered either directly or indirectly.

Promoter Holdings

Mahesh Paharaj Makhija, a promoter of the company, declared a holding of 1,28,48,840 equity shares. This constitutes the largest individual holding among the disclosures provided to the exchange.

Promoter Group Holdings

Members of the promoter group also submitted their annual disclosures. Guddi Mahesh Makhija reported holding 1,59,630 equity shares, while Diti Mahesh Makhija disclosed a holding of 1,63,116 equity shares. Both individuals confirmed that their respective shareholdings are free from any encumbrance.

The following table summarizes the disclosed shareholding details as of March 31, 2026:

Shareholder	Category	Equity Shares Held
Mahesh Paharaj Makhija	Promoter	1,28,48,840
Guddi Mahesh Makhija	Promoter Group	1,59,630
Diti Mahesh Makhija	Promoter Group	1,63,116

The disclosures were signed and submitted by the respective shareholders on April 6, 2026. The company, through its Company Secretary and Compliance Officer Toral Jailesh Bhadra, forwarded these details to the stock exchange on April 7, 2026.

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
-1.62%	+4.12%	+1.11%	-0.98%	+5.88%	-29.13%

QMS Medical Allied Services reported a 13% decline in consolidated net profit to ₹119.17 crore for the year ended March 31, 2026, despite an 11% rise in revenue from operations to ₹172.9 crore. Rising expenses impacted the bottom line, with total expenses increasing to ₹157.49 crore from ₹139.07 crore in the previous year. Profit before tax stood at ₹164.40 crore compared to ₹186.62 crore in FY25. The company released its investor presentation for Q4 and FY26 on June 04, 2026, detailing its operational highlights and strategic initiatives.

The board, in its meeting held on May 30, 2026, recommended a final dividend of ₹0.50 per equity share, or 5%, subject to shareholder approval. H.H. Dedhia And Associates, the statutory auditors, issued an unmodified opinion on the financial statements. The board also approved the re-appointment of M/s. Khushbu Parekh & Co., Chartered Accountants, as internal auditors for FY 2026-27 and the Information Memorandum for migration from the NSE Emerge platform to the main board.

Consolidated Financial Performance

Profit attributable to owners of the company declined to ₹101.32 crore from ₹120.92 crore, while non-controlling interest accounted for ₹17.85 crore. Basic and diluted earnings per share (EPS) fell to ₹5.40 from ₹6.65. The consolidated results include subsidiary Saarthi Healthcare Private Limited, which reported total assets of ₹43.28 crore as of March 31, 2026.

Particulars	FY26 (₹ in Cr)	FY25 (₹ in Cr)
Revenue From Operations	172.9	156.0
Other Income	1.1	1.7
Total Income	173.9	157.7
Total Expenses	157.5	139.1
Profit Before Tax	16.4	18.7
Net Profit (Total)	11.9	13.7
Profit Attributable to Owners	10.1	12.1
Basic EPS (₹)	5.40	6.65

Standalone Financial Performance

On a standalone basis, net profit fell to ₹66.91 crore from ₹104.21 crore in FY25. Revenue from operations grew to ₹152.30 crore from ₹144.87 crore, while total expenses rose to ₹143.20 crore from ₹130.90 crore. Profit before tax was ₹94.52 crore, down from ₹144.22 crore in the prior year.